Clinical Trials Logo

Filter by:
NCT ID: NCT01659580 Completed - Angina Pectoris Clinical Trials

Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina

CAESA
Start date: August 2012
Phase: Phase 3
Study type: Interventional

This phase III study is designed as a double blind, randomized, multi-nation, multi-center, placebo controlled clinical research, which aims to evaluate the safety and efficacy of Dantonic® (T89) in patients with chronic stable angina pectoris.

NCT ID: NCT01658098 Not yet recruiting - Clinical trials for Postpartum Depression

Prevalence of Postpartum Depression in Hospital Jose E. Gonzalez

Start date: September 2012
Phase: N/A
Study type: Observational

This research will use the Edinburgh Scale Of Post partum depression to evaluate patients during their 4th to 6th after delivery, and the investigators will compare the results with those found in other countries with population with similar characteristics as ours

NCT ID: NCT01657266 Completed - Cataract Clinical Trials

Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification

Start date: December 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of the ophthalmic solution PRO-155 in patients post phacoemulsification.

NCT ID: NCT01657253 Completed - Dry Eye Clinical Trials

Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye

Start date: November 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of the ophthalmic solution PRO-148 in the ocular surface of patients with mild to moderate dry eye compared with ophthalmic solution Systane®

NCT ID: NCT01655121 Completed - Cirrhosis Clinical Trials

Effect of High-protein High-fiber Diet in Patients With Autoimmune Hepatitis

Start date: January 2012
Phase: N/A
Study type: Interventional

Autoimmune hepatitis is a chronic disease of the liver caused by an alteration of the immune response that attacks the body's own hepatocytes, progressively, leading to cirrhosis and liver failure. There are few studies on dietary management in hepatitis and most of theme have focused on micronutrients specifically vitamin D to prevent osteoporosis, and decreased symptoms of other diseases associated, but few recommendations have been made regarding a complete dietary approach. Fiber has been proven to increase the excretion of nitrogen products and consequently reduce its blood levels and an adequate protein intake (1.2g/kg) has shown to decrease endogenous catabolism in cirrhotics patients. The implementation of a high protein high fiber nutrition plan and improves nutritional status of patients with autoimmune cirrhosis.

NCT ID: NCT01655069 Completed - Clinical trials for Urinary Bladder, Overactive

A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076

LEOPARD
Start date: October 4, 2012
Phase: Phase 3
Study type: Interventional

This was a 40-week study to investigate how safe and effective solifenacin solution was in treating children or adolescents with symptoms of overactive bladder (OAB), who completed study 905-CL-076 (NCT01565707).

NCT ID: NCT01652599 Completed - Clinical trials for Immune Thrombocytopenic Purpura

Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT

Start date: June 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the response rate and response duration with the combination of eltrombopag and high-dose dexamethasone

NCT ID: NCT01652131 Recruiting - Obesity Clinical Trials

Behaviour of Intravenous Solutions in Obese Patients Under General Anesthesia

Start date: May 2012
Phase: N/A
Study type: Interventional

There is no objective evidence of how long intravenous solutions remain inside venous blood vessels after they have been administered, therefore there is no definite guideline of how to administer them in the preoperative setting. Besides, obese patients represent a particular group of subjects as they theoretically with-hold a constant inflammatory response and that would modify the way solutions behave intravenously, that is how long they remain inside. Having said this, we wish to describe the way colloid solutions behave in this group of patients by taking serial blood samples in 12 obese patients after a colloid infusion, to calculate plasma dilution curves based on hemoglobin dilution and therefore infer the time it remains intravascularly. All this in the hope this information will help, in the near future, to establish a more objective way to use these solutions and avoid possible complications due to over-administration.

NCT ID: NCT01650181 Completed - Liver Disease Clinical Trials

Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis

Start date: November 2011
Phase: Phase 4
Study type: Interventional

Non-alcoholic steatohepatitis represents 10 - 15% total cases of hepatic cirrhosis. In the upcoming years, the economic burden of this disease will increase and will mean an important problem for our health system due to obesity epidemic. There are several treatments for non-alcoholic steatohepatitis; however, none of them have overcome a healthy lifestyle including diet, exercise and some drugs related with insulin metabolism. There after, using hepatoprotective drugs and antioxidants have been recommended as an eligible therapy to reduce the progression from fatty liver to steatohepatitis and cirrhosis. Being this approach not only an experimental item yet but also an unavoidable reality. The purpose of this randomized controlled study is explore the effects of siliphos-selenium-methionine-alpha lipoic acid + metformin versus metformin in patients with fatty liver and non-alcoholic steatohepatitis about biochemical and echosonographic parameters.

NCT ID: NCT01650064 Completed - Hip Fractures Clinical Trials

Latin America Hip Fracture Mortality Study

LAMOS
Start date: January 2013
Phase:
Study type: Observational

The purpose of this study is to estimate the survival proportion one year after surgery for intertrochanteric fracture in older adults in Latin America.